These antibodies have been fully validated by western blotting, and in many cases, tested in immunoflourescence, ELISA and immunoprecipitation assays. In addition to antibodies against cardiovascular targets, we source and re-validate highly specific antibodies from academic leaders. Our aim is to provide products that work first time in the applications you deploy, which accelerate the progress of your research, and which satisfy your expectations in every way.

Highly specific monoclonal and polyclonal antibodies are pivotal to the success of programs of research. Successful application of each antibody product in Western blot (WB), immunofluorescence microscopy (IF), and functional assays is indicated where we have direct evidence. Antibodies may prove suitable for use in additional formats of immunoassay.